论文信息 - Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.

Guidelines of Polish National Societies Diagnostics and Treatment of Thyroid Carcinoma. 2018 Update.

Significant advances have been made in thyroid can-cer research in recent years, therefore relevant clinical guidelines need to be updated. The current Polish guidelines "Diagnostics and Treatment of Thyroid Carcinoma" have been formulated at the "Thyroid Cancer and Other Malignancies of Endocrine Glands" conference held in Wisła in November 2015 [1].

[1] E. Chmielik,et al. Dynamic risk stratification in the follow-up of thyroid cancer: what is still to be discovered in 2017? , 2017, Endocrine-related cancer.

[2] E. Cibas,et al. The 2017 Bethesda System for Reporting Thyroid Cytopathology. , 2017, Journal of the American Society of Cytopathology.

[3] Gilles Russ,et al. European Thyroid Association Guidelines for Ultrasound Malignancy Risk Stratification of Thyroid Nodules in Adults: The EU-TIRADS , 2017, European Thyroid Journal.

[4] Jonn Wu,et al. The role of external beam radiation therapy in well-differentiated thyroid cancer , 2017, Expert review of anticancer therapy.

[5] T. Zelinka,et al. The penetrance of MEN2 pheochromocytoma is not only determined by RET mutations. , 2017, Endocrine-related cancer.

[6] B. Jarzab,et al. Advances in small molecule therapy for treating metastatic thyroid cancer , 2017, Expert opinion on pharmacotherapy.

[7] R. Wong,et al. Management of the lateral neck in well differentiated thyroid cancer. , 2017, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[8] P. Tauchi-Nishi,et al. Metastatic neoplasms to the thyroid diagnosed by fine-needle aspiration/core needle biopsy: Clinicopathologic and cytomorphologic correlation , 2017, CytoJournal.

[9] F. Pacini. Which patient with thyroid cancer deserves systemic therapy and when? , 2017, Best practice & research. Clinical endocrinology & metabolism.

[10] A. Benider,et al. Lung adenocarcinoma with thyroid metastasis: a case report , 2017, BMC Research Notes.

[11] D. Carvalho,et al. Malignant melanoma with synchronous thyroid metastases: case report and literature review , 2017, Archives of endocrinology and metabolism.

[12] D. Słowińska-Klencka,et al. The predictive value of sonographic images of follicular lesions – a comparison with nodules unequivocal in FNA – single centre prospective study , 2016, BMC Endocrine Disorders.

[13] E. Gubała,et al. The role of FDG-PET in localization of recurrent lesions of differentiated thyroid cancer (DTC) in patients with asymptomatic hyperthyroglobulinemia in a real clinical practice. , 2016, European journal of endocrinology.

[14] K. Woliński,et al. The usefulness of fluorine-18 fluorodeoxyglucose PET in the detection of recurrence in patients with differentiated thyroid cancer with elevated thyroglobulin and negative radioiodine whole-body scan , 2016, Nuclear medicine communications.

[15] S. Davis,et al. Radiotherapy in well‐differentiated thyroid cancer: is it underutilized? , 2016, ANZ journal of surgery.

[16] H. Dralle,et al. Surgical cure rates of sporadic medullary thyroid cancer in the era of calcitonin screening. , 2016, European journal of endocrinology.

[17] R. Davenport,et al. Metastatic ductal carcinoma of the breast to the thyroid gland diagnosed with fine needle aspiration: A case report with emphasis on morphologic and immunophenotypic features , 2016, Diagnostic cytopathology.

[18] D. Lange,et al. The diagnosis of cancer in thyroid fine needle aspiration biopsy. Surgery, repeat biopsy or specimen consultation? , 2016, Polish journal of pathology : official journal of the Polish Society of Pathologists.

[19] S. Roman,et al. Intensity-modulated radiation therapy use for the localized treatment of thyroid cancer: Nationwide practice patterns and outcomes , 2016, Endocrine.

[20] K. Meenakshisundaram,et al. The Bethesda System for reporting thyroid cytopathology: A two year retrospective review in a tertiary care hospital , 2016 .

[21] O. Lin,et al. Secondary tumors involving the thyroid gland: A multi‐institutional analysis of 28 cases diagnosed on fine‐needle aspiration , 2015, Diagnostic cytopathology.

[22] L. Pomorski,et al. The efficiency of elastography in the diagnostics of follicular lesions and nodules with an unequivocal FNA result. , 2015, Endokrynologia Polska.

[23] M. Ruchała,et al. Diagnosis, treatment, and prognosis in patients with liver metastases from follicular thyroid carcinoma (FTC). , 2015, Endokrynologia Polska.

[24] J. Shah,et al. Anaplastic Thyroid Carcinoma, Version 2.2015. , 2015, Journal of the National Comprehensive Cancer Network : JNCCN.

[25] A. Bossowski,et al. Practical Application of Elastography in the Diagnosis of Thyroid Nodules in Children and Adolescents , 2015, Hormone Research in Paediatrics.

[26] M. Schlumberger,et al. Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[27] O. Dekkers,et al. European Society of Endocrinology Clinical Guideline: Treatment of chronic hypoparathyroidism in adults. , 2015, European journal of endocrinology.

[28] M. Luster,et al. Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer. , 2015, Thyroid : official journal of the American Thyroid Association.

[29] Douglas B. Evans,et al. Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[30] B. Jarzab,et al. Adjuvant radioiodine (RAI) treatment reduces the risk of relapse in low advanced differentiated thyroid carcinoma (DTC) , 2015 .

[31] Sung-Bae Kim,et al. Lenvatinib versus placebo in radioiodine-refractory thyroid cancer. , 2015, The New England journal of medicine.

[32] M. Schlumberger,et al. Treatment of distant metastases from follicular cell-derived thyroid cancer , 2015, F1000prime reports.

[33] K. Chung,et al. Postoperative simultaneous integrated boost-intensity modulated radiation therapy for patients with locoregionally advanced papillary thyroid carcinoma: preliminary results of a phase II trial and propensity score analysis. , 2015, The Journal of clinical endocrinology and metabolism.

[34] K. Dobruch-Sobczak,et al. Shear wave elastography in medullary thyroid carcinoma diagnostics , 2015, Journal of ultrasonography.

[35] B. Jarzab,et al. Novel therapies for thyroid cancer , 2014, Expert opinion on pharmacotherapy.

[36] A. Czarnywojtek,et al. The Usefulness of Standardized Uptake Value in Differentiation between Benign and Malignant Thyroid Lesions Detected Incidentally in 18F-FDG PET/CT Examination , 2014, PloS one.

[37] C. Spencer,et al. How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies , 2014, Current opinion in endocrinology, diabetes, and obesity.

[38] R. Paschke,et al. Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial , 2014, The Lancet.

[39] T. Zelinka,et al. Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study. , 2014, The Lancet. Oncology.

[40] D. Słowińska-Klencka,et al. Repeat FNA Significantly Lowers Number of False Negative Results in Patients with Benign Nodular Thyroid Disease and Features of Chronic Thyroiditis , 2014, International journal of endocrinology.

[41] Jeong Hyun Lee,et al. Candidates for Limited Lateral Neck Dissection among Patients with Metastatic Papillary Thyroid Carcinoma , 2014, World Journal of Surgery.

[42] J. Brierley,et al. Indications for the use of external beam radiation in thyroid cancer , 2014, Current opinion in oncology.

[43] M. Kreissl,et al. Cabozantinib in progressive medullary thyroid cancer. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[44] E. McDermott,et al. Thyroid lymphoma: recent advances in diagnosis and optimal management strategies. , 2013, The oncologist.

[45] J. Bosset,et al. [Radiation therapy in thyroid cancer]. , 2013, Cancer Radiothérapie.

[46] D. Słowińska-Klencka,et al. Low malignancy risk of thyroid follicular lesion of undetermined significance in patients from post-endemic areas. , 2013, European journal of endocrinology.

[47] M. Alevizaki. Management of hyperparathyroidism (PHP) in MEN2 syndromes in Europe , 2013, Thyroid Research.

[48] H. Holzhausen,et al. Hypercalcitoninemia in thyroid conditions other than medullary thyroid carcinoma: a comparative analysis of calcium and pentagastrin stimulation of serum calcitonin , 2013, Langenbeck's Archives of Surgery.

[49] H. Dralle,et al. Surgical management of the lateral neck compartment for metastatic thyroid cancer , 2013, Current opinion in oncology.

[50] Y. Nikiforov,et al. American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer. , 2012, Thyroid : official journal of the American Thyroid Association.

[51] L. Mazzucchelli,et al. The Bethesda System for Reporting Thyroid Cytopathology: A Meta-Analysis , 2012, Acta Cytologica.

[52] J. Brierley,et al. The role of external beam radiation and targeted therapy in thyroid cancer. , 2012, Seminars in radiation oncology.

[53] M. Schlumberger,et al. Strategies of radioiodine ablation in patients with low-risk thyroid cancer. , 2012, The New England journal of medicine.

[54] S. Mandel,et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[55] Juan Rosai,et al. A large multicenter correlation study of thyroid nodule cytopathology and histopathology. , 2011, Thyroid : official journal of the American Thyroid Association.

[56] B. Fervers,et al. Guideline adaptation: an approach to enhance efficiency in guideline development and improve utilisation , 2011, Quality and Safety in Health Care.

[57] E. Gubała,et al. Radioiodine thyroid remnant ablation in patients with differentiated thyroid carcinoma (DTC): prospective comparison of long-term outcomes of treatment with 30, 60 and 100 mCi , 2010, Thyroid research.

[58] E. Chmielik,et al. Prognostic value of lymph node metastases of differentiated thyroid cancer (DTC) according to the local advancement and range of surgical excision , 2010, Thyroid research.

[59] B. Jarzab,et al. Urinary iodine in patients with differentiated thyroid cancer (DTC) during L-thyroxine treatment. , 2010, Endokrynologia Polska.

[60] Yoo Seok Jung,et al. The effect of external beam radiotherapy volume on locoregional control in patients with locoregionally advanced or recurrent nonanaplastic thyroid cancer , 2010, Radiation oncology.

[61] B. Jarzab,et al. 13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-Functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study , 2009, Thyroid research.

[62] A. Garden,et al. Postoperative external beam radiotherapy for differentiated thyroid cancer: outcomes and morbidity with conformal treatment. , 2009, International journal of radiation oncology, biology, physics.

[63] W. Oyen,et al. Guidelines for radioiodine therapy of differentiated thyroid cancer , 2008, European Journal of Nuclear Medicine and Molecular Imaging.

[64] R. Tsang,et al. External beam radiation therapy for thyroid cancer. , 2008, Endocrinology and metabolism clinics of North America.

[65] A. Signore,et al. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma , 2007, European Journal of Nuclear Medicine and Molecular Imaging.

[66] C. Kwan,et al. Local and regional control in patients with papillary thyroid carcinoma: specific indications of external radiotherapy and radioactive iodine according to T and N categories in AJCC 6th edition. , 2006, Endocrine-related cancer.

[67] William D Middleton,et al. Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement. , 2006, Radiology.

[68] A. Czarniecka,et al. [Hypoparathyroidism after surgery on thyroid cancer: is there a delayed chance for recovery after a prolonged period of substitutive therapy?]. , 2006, Endokrynologia Polska.

[69] E. Gubała,et al. [Relapse of differentiated thyroid carcinoma in low-risk patients]. , 2006, Endokrynologia Polska.

[70] M. Niedziela,et al. Pathogenesis, diagnosis and management of thyroid nodules in children. , 2006, Endocrine-related cancer.

[71] Jeffrey E. Lee,et al. Preventable reoperations for persistent and recurrent papillary thyroid carcinoma. , 2004, Surgery.

[72] A. Miyauchi,et al. Preoperative Ultrasonographic Examination for Lymph Node Metastasis: Usefulness when Designing Lymph Node Dissection for Papillary Microcarcinoma of the Thyroid , 2004, World Journal of Surgery.

[73] N. Willich,et al. Acute Toxicity of Adjuvant Radiotherapy in Locally Advanced Differentiated Thyroid Carcinoma , 2003, Strahlentherapie und Onkologie.

[74] B. Seifert,et al. Lymph node surgery in papillary thyroid carcinoma. , 2003, Journal of the American College of Surgeons.

[75] P. Larsen,et al. Natural History of Benign Solid and Cystic Thyroid Nodules , 2003, Annals of Internal Medicine.

[76] Mary C Frates,et al. Assessment of nondiagnostic ultrasound-guided fine needle aspirations of thyroid nodules. , 2002, The Journal of clinical endocrinology and metabolism.

[77] M. Wiench,et al. Estimation of risk of inherited medullary thyroid carcinoma in apparent sporadic patients. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[78] D. Rubello,et al. The role of external beam radiotherapy in the management of differentiated thyroid cancer. , 2000, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[79] C. Eng,et al. Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine. , 1998, The Journal of clinical endocrinology and metabolism.

[80] C Eng,et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. , 1996, JAMA.

[81] J H Lubin,et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. , 1995, Radiation research.

[82] Kaliszewski,et al. American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[83] D. Lange,et al. Clinical importance of follicular lesion of undetermined significance (diagnostic category III according to Bethesda System) diagnosed from Fine-Needle Aspiration Biopsy. , 2016, Endokrynologia Polska.

[84] E. Gubała,et al. Ongoing risk stratification for differentiated thyroid cancer (DTC) - stimulated serum thyroglobulin (Tg) before radioiodine (RAI) ablation, the most potent risk factor of cancer recurrence in M0 patients. , 2016, Endokrynologia Polska.

[85] S. Półtorak,et al. Suspicious for follicular neoplasm or follicular neoplasm? The dilemma of a pathologist and a surgeon. , 2016, Endokrynologia Polska.

[86] B. Jarzab,et al. Occurrence of phaeochromocytoma tumours in RET mutation carriers - a single-centre study. , 2016, Endokrynologia Polska.

[87] K. Jażdżewski,et al. Diagnostics and Treatment of Thyroid Carcinoma. , 2016, Endokrynologia Polska.

[88] L. Pomorski,et al. Analysis of clinical significance of equivocal thyroid cytology with a special consideration for FLUS category - five years of new classification of FNA results. , 2016, Endokrynologia Polska.

[89] M. Ruchała,et al. Diagnostics and treatment of differentiated thyroid carcinoma in children - Guidelines of Polish National Societies. , 2016, Endokrynologia Polska.

[90] H. Dralle,et al. Surgical Treatment of Medullary Thyroid Cancer. , 2015, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.

[91] Dharmendra Kumar,et al. The Bethesda System for Reporting Thyroid Cytopathology , 2014 .

[92] A. Lewiński,et al. Metastases of renal clear‑cell carcinoma to the thyroid: a comparison of shear‑wave and quasi‑static elastography. , 2014, Polskie Archiwum Medycyny Wewnetrznej.

[93] K. Woliński,et al. How to select nodules for fine-needle aspiration biopsy in multinodular goitre. Role of conventional ultrasonography and shear wave elastography - a preliminary study. , 2014, Endokrynologia Polska.

[94] K. Dobruch‑Sobczak,et al. Standardy badań ultrasonograficznych Polskiego Towarzystwa Ultrasonograficznego - aktualizacja. Badanie ultrasonograficzne tarczycy oraz biopsja tarczycy pod kontrolą ultrasonografii Standards of the Polish Ultrasound Society - update. Ultrasound examination of thyroid gland and ultrasound-guided th , 2014 .

[95] M. Schott. Vandetanib in Patients With Locally Advanced or Metastatic Medullary Thyroid Cancer: A Randomized, Double-Blind Phase III Trial , 2012 .

[96] B. Modan,et al. Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995. , 2012, Radiation research.

[97] A. Czarnywojtek,et al. Incidental ¹⁸F-FDG uptake in the thyroid in patients diagnosed with PET/CT for other malignancies. , 2011, Nuclear medicine review. Central & Eastern Europe.

[98] R. Negro,et al. 2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum. , 2011, Thyroid : official journal of the American Thyroid Association.

[99] G. Karanikas,et al. Calcitonin measurements for early detection of medullary thyroid carcinoma or its premalignant conditions in Hashimoto's thyroiditis. , 2006, Anticancer research.